Barclays
KALA icon

Barclays’s KALA BIO KALA Stock Holding History

Barclays’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05K Buy
+608
New +$2.95K ﹤0.01% 4927
2022
Q2 		– Sell
-9
Closed -$31K – 5152
2022
Q1 		$31K Sell
9
-20
-69% -$52.4K ﹤0.01% 4297
2021
Q4 		$88K Buy
29
+15
+107% +$69.6K ﹤0.01% 3755
2021
Q3 		$88K Buy
14
+4
+40% +$34.5K ﹤0.01% 3956
2021
Q2 		$125K Sell
10
-14
-58% -$220K ﹤0.01% 3758
2021
Q1 		$403K Buy
24
+19
+380% +$371K ﹤0.01% 3308
2020
Q4 		$88K Sell
5
-7
-58% -$132K ﹤0.01% 4184
2020
Q3 		$218K Sell
12
-52
-81% -$1.2M ﹤0.01% 3792
2020
Q2 		$1.68M Buy
64
+58
+967% +$1.64M ﹤0.01% 2288
2020
Q1 		$131K Sell
6
-3
-33% -$47.9K ﹤0.01% 4603
2019
Q4 		$83K Buy
9
+4
+80% +$38.6K ﹤0.01% 5563
2019
Q3 		$50K Sell
5
-1
-17% -$12.2K ﹤0.01% 5906
2019
Q2 		$102K Buy
6
+3
+100% +$49.7K ﹤0.01% 5680
2019
Q1 		$61K Buy
3
+2
+200% +$35.5K ﹤0.01% 5728
2018
Q4 		$10K Sell
1
-2
-67% -$34.7K ﹤0.01% 6172
2018
Q3 		$62K Sell
3
-1
-25% -$30.5K ﹤0.01% 5932
2018
Q2 		$129K Buy
4
+2
+100% +$76.7K ﹤0.01% 5070
2018
Q1 		$89K Buy
2
+1
+100% +$38K ﹤0.01% 5462
2017
Q4 		$65K Sell
1
-4
-80% -$187K ﹤0.01% 5563
2017
Q3 		$273K Buy
+5
New +$274K ﹤0.01% 4158

Other funds holding KALA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barclays's KALA Position: Q2 2026 in Review

Barclays opened a new position in KALA BIO (KALA) in Q2 2026: 608 shares worth $1.05K. The stake represents ﹤0.01% of the portfolio and ranks #4927 among its holdings. This is a return to the name: Barclays previously reported a position in KALA as recently as Q1 2022.

Barclays first reported a position in KALA in Q3 2017 and has held it in 20 quarters since. The position peaked at $1.68M in Q2 2020. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • Barclays held 608 shares of KALA BIO worth $1.05K as of Q2 2026.
  • KALA BIO was a new Barclays position in Q2 2026.
  • KALA BIO made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4927 holding.
  • Barclays first reported a position in KALA BIO in Q3 2017 and has held it in 20 quarters since.
  • Barclays's KALA BIO position peaked at $1.68M in Q2 2020.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.